Can amiodarone and amlodipine be co‑administered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Amiodarone and Amlodipine Be Taken Together?

Yes, amiodarone and amlodipine can be safely co-administered together without significant pharmacokinetic interaction or need for dose adjustment of either medication. 1

Evidence Supporting Safe Co-Administration

Pharmacokinetic Compatibility

  • Amlodipine does not require dose adjustment when combined with amiodarone, as there is no evidence of significant pharmacokinetic interaction between these two agents 1
  • Unlike other calcium channel blockers (diltiazem and verapamil), amlodipine does not substantially interact with amiodarone's metabolism or effects 1
  • Amlodipine is a CYP3A4 substrate, but amiodarone's inhibition of this enzyme does not produce clinically significant changes in amlodipine plasma concentrations 1

Clinical Trial Evidence

  • Multiple studies have successfully used amiodarone combined with amlodipine without reporting safety concerns or adverse interactions 2, 3
  • In a randomized trial of 250 hypertensive patients with atrial fibrillation, the combination of amiodarone plus amlodipine was well-tolerated over 12 months of follow-up 2
  • A study of 296 hypertensive diabetic patients demonstrated safe co-administration of amlodipine with amiodarone (or propafenone) for one year without interaction-related adverse events 3

Critical Distinction from Other Calcium Channel Blockers

Why Amlodipine Is Different

  • Diltiazem and verapamil carry significant interaction risks with amiodarone due to additive effects on sinus node function and AV nodal conduction, potentially causing severe bradycardia and sinus arrest 4, 5
  • These non-dihydropyridine calcium channel blockers (diltiazem, verapamil) should be avoided or used with extreme caution when combined with amiodarone 4
  • Amlodipine, as a dihydropyridine calcium channel blocker, does not share these electrophysiologic interactions because it has minimal effects on cardiac conduction tissue 1

Monitoring Recommendations

Standard Amiodarone Monitoring Applies

  • Check baseline and every 6-month thyroid function tests (TSH), liver transaminases, and perform directed history and physical examination 6
  • Obtain baseline ECG to assess PR interval, QRS duration, and QT interval 6
  • Monitor heart rate regularly, though amlodipine does not add significant bradycardic risk 6

Blood Pressure Monitoring

  • Monitor blood pressure response to the combination, as both agents lower blood pressure through different mechanisms 2, 3
  • The combination provides effective blood pressure control in hypertensive patients without requiring dose adjustments for the interaction itself 2, 3

Important Drug Interactions to Monitor with Amiodarone

High-Priority Interactions (Not Related to Amlodipine)

  • Digoxin: Reduce dose by 50% immediately when starting amiodarone, as digoxin levels typically double 7, 6
  • Warfarin: Monitor INR at least weekly for the first 6 weeks and reduce warfarin dose by approximately 50%, as peak interaction occurs around 7 weeks 6
  • Simvastatin: Limit to maximum 20 mg daily when combined with amiodarone due to increased myopathy risk 1

Avoid These Combinations

  • Do not combine amiodarone with diltiazem or verapamil unless absolutely necessary and with intensive cardiac monitoring, due to severe bradycardia and sinus arrest risk 4, 5
  • Consider amlodipine as the preferred calcium channel blocker when rate control or blood pressure management is needed in patients on amiodarone 4

Common Pitfalls to Avoid

  • Do not confuse amlodipine with diltiazem or verapamil – only the non-dihydropyridine calcium channel blockers carry significant interaction risks with amiodarone 1, 4
  • Do not unnecessarily reduce amlodipine dose when starting amiodarone, as no pharmacokinetic interaction necessitates this adjustment 1
  • Remember that amiodarone's extremely long half-life (26-107 days) means interactions can persist for months after discontinuation, though this does not apply to the amlodipine combination 1, 6
  • Focus monitoring efforts on amiodarone's well-established interactions (digoxin, warfarin, statins) rather than on the safe amlodipine combination 7, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Potential Interactions Between Amiodarone and Verapamil

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pharmacokinetic drug interactions with amiodarone.

Clinical pharmacokinetics, 1989

Guideline

Amiodarone Monitoring Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Digoxin-Amiodarone Interaction Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.